Surgery Partners, Inc. (SGRY) has a MoatMap StockRank of 50/100 based on Quality (44/100), Value (55/100), and Momentum (38/100) factor scores. The current signal is HOLD. Surgery Partners benefits from the secular shift of surgical procedures to lower-cost outpatient settings. While the business has solid growth prospects, its high debt load and regulatory risks prevent it from being a high-conviction compounder at this stage.
Surgery Partners, Inc. operates a comprehensive network of surgical facilities, encompassing ambulatory surgery centers (ASCs) and surgical hospitals, alongside ancillary services like urgent care centers and physician practices. The company focuses on delivering high-quality, cost-effective surgical care in outpatient settings. Surgery Partners is strategically positioned to capitalize on the ongoing shift of medical procedures from inpatient hospitals to more efficient outpatient facilities.
| Price | $13.96 |
| Market Cap | $1.8B |
| P/E (Forward) | 21.33 |
| Price/Book | 1.05 |
| Return on Equity | 2.7% |
| Return on Invested Capital | 5.2% |
| Debt/Equity | 116.01 |
| Gross Margin | 22.8% |
| Operating Margin | 10.4% |
| Revenue Growth | 4.5% |
| Free Cash Flow | $199M |
Surgery Partners, Inc. operates in the Medical Care Facilities industry, part of the Healthcare sector (United States).